Global Doxorubicin Injection Market Outlook 2022

SKU ID : QYR-19758752 | Publishing Date : 21-Dec-2021 | No. of pages : 100

Detailed TOC of Global Doxorubicin Injection Market Outlook 2022

1 Doxorubicin Injection Market Overview
    1.1 Product Overview and Scope of Doxorubicin Injection
    1.2 Doxorubicin Injection Segment by Type
        1.2.1 Global Doxorubicin Injection Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 5ml/vial
        1.2.3 10ml/vial
        1.2.4 50ml/vial
    1.3 Doxorubicin Injection Segment by Application
        1.3.1 Global Doxorubicin Injection Sales Comparison by Application: (2021-2027)
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Recovery Center
    1.4 Global Doxorubicin Injection Market Size Estimates and Forecasts
        1.4.1 Global Doxorubicin Injection Revenue 2016-2027
        1.4.2 Global Doxorubicin Injection Sales 2016-2027
        1.4.3 Doxorubicin Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Doxorubicin Injection Market Competition by Manufacturers
    2.1 Global Doxorubicin Injection Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Doxorubicin Injection Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Doxorubicin Injection Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Doxorubicin Injection Manufacturing Sites, Area Served, Product Type
    2.5 Doxorubicin Injection Market Competitive Situation and Trends
        2.5.1 Doxorubicin Injection Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Doxorubicin Injection Players Market Share by Revenue
        2.5.3 Global Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Doxorubicin Injection Retrospective Market Scenario by Region
    3.1 Global Doxorubicin Injection Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Doxorubicin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Doxorubicin Injection Market Facts & Figures by Country
        3.3.1 North America Doxorubicin Injection Sales by Country
        3.3.2 North America Doxorubicin Injection Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Doxorubicin Injection Market Facts & Figures by Country
        3.4.1 Europe Doxorubicin Injection Sales by Country
        3.4.2 Europe Doxorubicin Injection Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Doxorubicin Injection Market Facts & Figures by Region
        3.5.1 Asia Pacific Doxorubicin Injection Sales by Region
        3.5.2 Asia Pacific Doxorubicin Injection Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Doxorubicin Injection Market Facts & Figures by Country
        3.6.1 Latin America Doxorubicin Injection Sales by Country
        3.6.2 Latin America Doxorubicin Injection Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Doxorubicin Injection Market Facts & Figures by Country
        3.7.1 Middle East and Africa Doxorubicin Injection Sales by Country
        3.7.2 Middle East and Africa Doxorubicin Injection Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Doxorubicin Injection Historic Market Analysis by Type
    4.1 Global Doxorubicin Injection Sales Market Share by Type (2016-2021)
    4.2 Global Doxorubicin Injection Revenue Market Share by Type (2016-2021)
    4.3 Global Doxorubicin Injection Price by Type (2016-2021)

5 Global Doxorubicin Injection Historic Market Analysis by Application
    5.1 Global Doxorubicin Injection Sales Market Share by Application (2016-2021)
    5.2 Global Doxorubicin Injection Revenue Market Share by Application (2016-2021)
    5.3 Global Doxorubicin Injection Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Hikma
        6.1.1 Hikma Corporation Information
        6.1.2 Hikma Description and Business Overview
        6.1.3 Hikma Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Hikma Doxorubicin Injection Product Portfolio
        6.1.5 Hikma Recent Developments/Updates
    6.2 Athenex
        6.2.1 Athenex Corporation Information
        6.2.2 Athenex Description and Business Overview
        6.2.3 Athenex Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Athenex Doxorubicin Injection Product Portfolio
        6.2.5 Athenex Recent Developments/Updates
    6.3 Fresenius Kabi
        6.3.1 Fresenius Kabi Corporation Information
        6.3.2 Fresenius Kabi Description and Business Overview
        6.3.3 Fresenius Kabi Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Fresenius Kabi Doxorubicin Injection Product Portfolio
        6.3.5 Fresenius Kabi Recent Developments/Updates
    6.4 Mylan
        6.4.1 Mylan Corporation Information
        6.4.2 Mylan Description and Business Overview
        6.4.3 Mylan Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Mylan Doxorubicin Injection Product Portfolio
        6.4.5 Mylan Recent Developments/Updates
    6.5 Sagent
        6.5.1 Sagent Corporation Information
        6.5.2 Sagent Description and Business Overview
        6.5.3 Sagent Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Sagent Doxorubicin Injection Product Portfolio
        6.5.5 Sagent Recent Developments/Updates
    6.6 Teva
        6.6.1 Teva Corporation Information
        6.6.2 Teva Description and Business Overview
        6.6.3 Teva Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Teva Doxorubicin Injection Product Portfolio
        6.6.5 Teva Recent Developments/Updates
    6.7 Caraco
        6.6.1 Caraco Corporation Information
        6.6.2 Caraco Description and Business Overview
        6.6.3 Caraco Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Caraco Doxorubicin Injection Product Portfolio
        6.7.5 Caraco Recent Developments/Updates

7 Doxorubicin Injection Manufacturing Cost Analysis
    7.1 Doxorubicin Injection Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Doxorubicin Injection
    7.4 Doxorubicin Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Doxorubicin Injection Distributors List
    8.3 Doxorubicin Injection Customers

9 Doxorubicin Injection Market Dynamics
    9.1 Doxorubicin Injection Industry Trends
    9.2 Doxorubicin Injection Growth Drivers
    9.3 Doxorubicin Injection Market Challenges
    9.4 Doxorubicin Injection Market Restraints

10 Global Market Forecast
    10.1 Doxorubicin Injection Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Doxorubicin Injection by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Doxorubicin Injection by Type (2022-2027)
    10.2 Doxorubicin Injection Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Doxorubicin Injection by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Doxorubicin Injection by Application (2022-2027)
    10.3 Doxorubicin Injection Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Doxorubicin Injection by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Doxorubicin Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Doxorubicin Injection Market Outlook 2022

List of Tables
    Table 1. Global Doxorubicin Injection Sales (K Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Doxorubicin Injection Sales (K Units) Comparison by Application (2021-2027)
    Table 3. Global Doxorubicin Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Doxorubicin Injection Covered in This Study
    Table 5. Global Doxorubicin Injection Sales (K Units) of Key Manufacturers (2016-2021)
    Table 6. Global Doxorubicin Injection Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Doxorubicin Injection Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Doxorubicin Injection Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Doxorubicin Injection Average Price (US$/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Doxorubicin Injection Manufacturing Sites and Area Served
    Table 11. Manufacturers Doxorubicin Injection Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Doxorubicin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxorubicin Injection as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Doxorubicin Injection Sales by Region (2016-2021) & (K Units)
    Table 16. Global Doxorubicin Injection Sales Market Share by Region (2016-2021)
    Table 17. Global Doxorubicin Injection Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Doxorubicin Injection Sales by Country (2016-2021) & (K Units)
    Table 19. North America Doxorubicin Injection Sales Market Share by Country (2016-2021)
    Table 20. North America Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Doxorubicin Injection Revenue Market Share by Country (2016-2021)
    Table 22. Europe Doxorubicin Injection Sales by Country (2016-2021) & (K Units)
    Table 23. Europe Doxorubicin Injection Sales Market Share by Country (2016-2021)
    Table 24. Europe Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Doxorubicin Injection Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Doxorubicin Injection Sales by Region (2016-2021) & (K Units)
    Table 27. Asia Pacific Doxorubicin Injection Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Doxorubicin Injection Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Doxorubicin Injection Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Doxorubicin Injection Sales by Country (2016-2021) & (K Units)
    Table 31. Latin America Doxorubicin Injection Sales Market Share by Country (2016-2021)
    Table 32. Latin America Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Doxorubicin Injection Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Doxorubicin Injection Sales by Country (2016-2021) & (K Units)
    Table 35. Middle East and Africa Doxorubicin Injection Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Doxorubicin Injection Revenue Market Share by Country (2016-2021)
    Table 38. Global Doxorubicin Injection Sales (K Units) by Type (2016-2021)
    Table 39. Global Doxorubicin Injection Sales Market Share by Type (2016-2021)
    Table 40. Global Doxorubicin Injection Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Doxorubicin Injection Revenue Share by Type (2016-2021)
    Table 42. Global Doxorubicin Injection Price (US$/Unit) by Type (2016-2021)
    Table 43. Global Doxorubicin Injection Sales (K Units) by Application (2016-2021)
    Table 44. Global Doxorubicin Injection Sales Market Share by Application (2016-2021)
    Table 45. Global Doxorubicin Injection Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Doxorubicin Injection Revenue Share by Application (2016-2021)
    Table 47. Global Doxorubicin Injection Price (US$/Unit) by Application (2016-2021)
    Table 48. Hikma Corporation Information
    Table 49. Hikma Description and Business Overview
    Table 50. Hikma Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 51. Hikma Doxorubicin Injection Product
    Table 52. Hikma Recent Developments/Updates
    Table 53. Athenex Corporation Information
    Table 54. Athenex Description and Business Overview
    Table 55. Athenex Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 56. Athenex Doxorubicin Injection Product
    Table 57. Athenex Recent Developments/Updates
    Table 58. Fresenius Kabi Corporation Information
    Table 59. Fresenius Kabi Description and Business Overview
    Table 60. Fresenius Kabi Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 61. Fresenius Kabi Doxorubicin Injection Product
    Table 62. Fresenius Kabi Recent Developments/Updates
    Table 63. Mylan Corporation Information
    Table 64. Mylan Description and Business Overview
    Table 65. Mylan Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 66. Mylan Doxorubicin Injection Product
    Table 67. Mylan Recent Developments/Updates
    Table 68. Sagent Corporation Information
    Table 69. Sagent Description and Business Overview
    Table 70. Sagent Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 71. Sagent Doxorubicin Injection Product
    Table 72. Sagent Recent Developments/Updates
    Table 73. Teva Corporation Information
    Table 74. Teva Description and Business Overview
    Table 75. Teva Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 76. Teva Doxorubicin Injection Product
    Table 77. Teva Recent Developments/Updates
    Table 78. Caraco Corporation Information
    Table 79. Caraco Description and Business Overview
    Table 80. Caraco Doxorubicin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 81. Caraco Doxorubicin Injection Product
    Table 82. Caraco Recent Developments/Updates
    Table 83. Production Base and Market Concentration Rate of Raw Material
    Table 84. Key Suppliers of Raw Materials
    Table 85. Doxorubicin Injection Distributors List
    Table 86. Doxorubicin Injection Customers List
    Table 87. Doxorubicin Injection Market Trends
    Table 88. Doxorubicin Injection Growth Drivers
    Table 89. Doxorubicin Injection Market Challenges
    Table 90. Doxorubicin Injection Market Restraints
    Table 91. Global Doxorubicin Injection Sales Forecast by Type (2022-2027) & (K Units)
    Table 92. Global Doxorubicin Injection Sales Market Share Forecast by Type (2022-2027)
    Table 93. Global Doxorubicin Injection Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 94. Global Doxorubicin Injection Revenue Market Share Forecast by Type (2022-2027)
    Table 95. Global Doxorubicin Injection Sales Forecast by Application (2022-2027) & (K Units)
    Table 96. Global Doxorubicin Injection Sales Market Share Forecast by Application (2022-2027)
    Table 97. Global Doxorubicin Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 98. Global Doxorubicin Injection Revenue Market Share Forecast by Application (2022-2027)
    Table 99. Global Doxorubicin Injection Sales Forecast by Region (2022-2027) & (K Units)
    Table 100. Global Doxorubicin Injection Sales Market Share Forecast by Region (2022-2027)
    Table 101. Global Doxorubicin Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 102. Global Doxorubicin Injection Revenue Market Share Forecast by Region (2022-2027)
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Doxorubicin Injection
    Figure 2. Global Doxorubicin Injection Market Share by Type in 2020 & 2027
    Figure 3. 5ml/vial Product Picture
    Figure 4. 10ml/vial Product Picture
    Figure 5. 50ml/vial Product Picture
    Figure 6. Global Doxorubicin Injection Market Share by Application in 2020 & 2027
    Figure 7. Hospital
    Figure 8. Clinics
    Figure 9. Recovery Center
    Figure 10. Global Doxorubicin Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Doxorubicin Injection Market Size 2016-2027 (US$ Million)
    Figure 12. Global Doxorubicin Injection Sales 2016-2027 (K Units)
    Figure 13. Global Doxorubicin Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Doxorubicin Injection Sales Share by Manufacturers in 2020
    Figure 15. Global Doxorubicin Injection Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Doxorubicin Injection Players: Market Share by Revenue in 2020
    Figure 17. Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Doxorubicin Injection Sales Market Share by Region (2016-2021)
    Figure 19. Global Doxorubicin Injection Sales Market Share by Region in 2020
    Figure 20. Global Doxorubicin Injection Revenue Market Share by Region (2016-2021)
    Figure 21. Global Doxorubicin Injection Revenue Market Share by Region in 2020
    Figure 22. U.S. Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Taiwan Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Philippines Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Vietnam Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Mexico Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Brazil Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Argentina Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Turkey Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Saudi Arabia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. UAE Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Sales Market Share of Doxorubicin Injection by Type (2016-2021)
    Figure 47. Sales Market Share of Doxorubicin Injection by Application (2016-2021)
    Figure 48. Sales Market Share of Doxorubicin Injection by Application in 2020
    Figure 49. Revenue Share of Doxorubicin Injection by Application (2016-2021)
    Figure 50. Revenue Share of Doxorubicin Injection by Application in 2020
    Figure 51. Manufacturing Cost Structure of Doxorubicin Injection
    Figure 52. Manufacturing Process Analysis of Doxorubicin Injection
    Figure 53. Doxorubicin Injection Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed